• Services
  • Attorneys
  • Media & Insights
  • Online Payment
Results may vary depending on your particular facts and legal circumstances. No aspect of this advertisement has been approved by the Supreme Court of New Jersey. A description of the selection methodology can be found here.
  • Services
  • Attorneys
  • Media & Insights
  • About Us
  • Delivering Value
  • Diversity & Inclusion
  • Meritas
  • Contact Us
  • Online Payment
    A
    Alternative Dispute ResolutionAntitrust & Trade RegulationAppellate Practice
    B
    Banking & Financial ServicesBankruptcy, Creditors’ Rights, and Financial RestructuringBeer LawBusiness Law
    C
    Cannabis LawConstruction LawCooperative and Condominium Law (Co-op & Condo)Criminal Defense
    E
    Economic Development LawElder Care & Special Needs LawElectronic Discovery ("E-Discovery")Environmental LawEstate Planning and Administration & Wealth PreservationExecutive Compensation and Employment Strategies
    F
    Food, Beverage & HospitalityFranchise Law
    H
    Health Care & Life SciencesHealth Care ProvidersHigher EducationHospitals and Health Networks
    I
    ImmigrationInsurance CoverageIntellectual PropertyIntellectual Property Litigation, Arbitration, and Dispute ResolutionIntellectual Property Portfolio Strategy, Management & LicensingInternational BusinessInternet Law
    L
    Labor & EmploymentLiquor Law, Licensing, Manufacturing, and DistributionLitigation
    M
    Media Law & Creative Economy PracticeMergers & AcquisitionsMunicipal Law
    N
    Non-Profit Law
    P
    Patent Preparation and ProsecutionPharmaceutical / Medical Devices / Pharma ServicesProducts and Consumer Liability DefenseProfessional LiabilityPublic Utilities
    R
    Real Estate, Finance, and Land Use
    S
    SecuritiesSolar Energy
    T
    TaxationTelecommunicationsTrademark & Copyright Protection & Enforcement
    V
    Venture Tech & Emerging Growth Companies
    W
    White Collar Investigations & DefenseWorkers’ Compensation
    • New Jersey
    • New York
    • Pennsylvania
    • Blogs
    • Articles
    • Podcasts
    • COVID-19 Resources

    Categories

    Banking Business and Tax Planning Business Law Coming to America Consumer Defense Criminal—White Collar Cyber Security and Data Protection E-Commerce General Health Care Immigration Intellectual Property Internet Law Labor & Employment Litigation Litigation>Product Liability Defense Outbound Rates REWIND Securities Taxation
    Blogs > Business Without Borders® > BWOB Rewind: An Update on...
    Member
    Robert C. Gabrielski
    Visit Profile

    BWOB Rewind: An Update on the Coronavirus and the COVID-19 Vaccine Around the World

    BWOB Rewind: An Update on the Coronavirus and the COVID-19 Vaccine Around the World

    Porto, Portugal – European Leaders met in person on Friday, May 7, 2021, for the first time this year.

    While they continued to wear face masks and their enthusiasm was guarded, it was evident that the virus has been waning in the EU. EU Commission President Ursula von der Leyen noted in her opening remarks that “[t]he (pandemic) recovery is still in an early stage…”  EU leaders appear to be trying to “convey a sense of normalcy, of slowly returning to normal” said Antonio Barroso, a Managing Director with Teneo. A focal point of the summit is to develop a plan to repair the economic damage inflicted by the COVID-19 pandemic, including the creation of a plan or protocol to share the vaccine technology to speed the end of the pandemic.

    From Barry Hatton, Associated Press

    Geneva, Switzerland – The World Health Organization gave its authorization on Friday, May 7, 2021, for the emergency use of a COVID-19 vaccine manufactured by China’s Sinopharm.

    The WHO authorization follows a decision by its technical advisory group that opens the prospect that the Sinopharm vaccine could be included in the United Nations-backed COVAX program. That program looks to distribute the vaccine through UNICEF and the WHO’s regional office for the Americas. While globally, the concern is to find methods to distribute the vaccines to countries in desperate need, Sinopharm has released little public data other than the efficacy numbers for the two vaccines developed by the Beijing Institute of Biological Products and the Wuhan Institute of Biological Products.

    From the Associated Press

    Tokyo, Japan – Japan continues to show social and political stress as the coronavirus spreads in the country.

    Japan extended its state of emergency in Tokyo through the end of May. How will the spread of the virus impact the Olympics, which are set to commence in less than three months? Will the Japanese be comfortable hosting the games? Surveys show that most residents of Japan oppose hosting the games during the pandemic, while the government is set on doing so. If cases don’t decline and the public becomes more concerned, how will that impact the games? Remember that the games, originally scheduled to take place last year, were postponed to 2021 in hopes that the virus would be under control – doesn’t look like that’s the case.

    From the Associated Press

    Rome, Italy – The United States proposed the possibility of waiving patent protections for the COVID-19 vaccine.

    The Director General of the World Trade Organization (WTO) stated that patent protection waiver discussions would ramp up within the WTO. Ngozi Okonjo-Iweala noted arguments both for and against the waiver, but said she was “sure (that the United States’) proposal will give impetus to negotiations.” In addition, the WTO brought up ways to address other logistical issues that could hamper getting the vaccines to where they’re needed, including eliminating or reducing export restrictions and the efficacy of distribution chains. Finally, Okonjo-Iweala said she hoped that the WTO members could “come together” to develop a plan to increase the distribution of the vaccines.

    From Thompson Reuters – reporting by Gavin Jones and editing by Angelo Amante

    If you have any questions about this post or any related international business matters, please feel free to contact me at rcgabrielski@norris-law.com.

    Member
    Robert C. Gabrielski
    Visit Profile

    Related Posts

    The Supply Chain Pandemic Continues: What Has Changed and What to Expect for the Holiday Season Scarecrows for Halloween? Video Games for Christmas? Maybe -- With “Black Friday” Barely a Month Away, Is the Supply Chain Bottleneck Holding up Your Holiday Shopping? U.S. Advisory Cautions Businesses Operating in Hong Kong About China’s Crackdown

    Share

    Tags

    #China #Coronavirus (COVID-19) #EU #Japan #United States

    Helpful links

    • About Us
    • News
    • Services
    • Blogs
    • Attorneys
    • Articles
    • (COVID-19)
    • Award Methodology
    • Events
    • Join our Team
    Connect
    Online Payment

    Connect with Us

    • LinkedIn
    • Facebook
    • Twitter
    • Instagram
    • Youtube

    Join our growing team

    We are looking for quality attorneys to help us do more for our clients. At Norris McLaughlin, each attorney has the same opportunity to succeed whether you’re at the beginning of a career or pinnacle of the profession.

    Learn More

    Subscribe to our content

    Receive timely legal information delivered to your inbox

    This field is for validation purposes and should be left unchanged.
    © , Norris McLaughlin, P.A., All Rights Reserved. Attorney Advertising.
    VIEW OUR DISCLAIMER,  TERMS OF USE,  AND PRIVACY POLICY

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume you consent to our cookie policy. Learn more